Form 8-K - Current report:
SEC Accession No. 0001104659-19-051657
Filing Date
2019-09-27
Accepted
2019-09-27 06:50:02
Documents
3
Period of Report
2019-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-19093_18k.htm 8-K 26781
2 EX-99.1 a19-19093_1ex99d1.htm EX-99.1 11356
3 GRAPHIC g190931mmi001.jpg GRAPHIC 4051
  Complete submission text file 0001104659-19-051657.txt   45118
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 191119575
SIC: 2834 Pharmaceutical Preparations